By Derek Skomorowski
Rule number one in essay writing class was “never choose a title before writing the essay.” Too bad, this title has a nice ring to it.
Actually, the first title of this commentary was going to be “What’s in a name?” because that would also have a nice ring to it. For anyone not up to speed on English literature, the quotes are attributable to none other than William Shakespeare – something about Juliet saying to Romeo, “What’s in a name? That which we call a rose by any other name would smell just as sweet.”
I never really understood this Shakespeare stuff, but the point is that names are irrelevant. “A rose by any other name” is still a rose, or something. Unless you’re naming an investment fund. Because the name of an investment fund should describe what an investment fund is trying to do.
We’re changing the name of EdgePoint Variable Income Portfolio, our high-conviction corporate credit (i.e., debt) portfolio that focuses on high yield bonds.i Not because we’re changing anything about the way we manage money, but because the previous name wasn’t helpful in making an investment decision. Specifically, helping you decide whether the (formerly known as) EdgePoint Variable Income Portfolio is worthy of your investment.
Before you think this commentary is only relevant to investors in our Variable Income Portfolio, this name change relates directly to the way we run money across all of our fixed income mandates.
Read the rest online: EdgePoint 4th Quarter – A Rose By Any Other Name
Download the article: Q4 2022- A Rose By Any Other Name
Comments are closed.